HYPOTENSIVE ACTIONS OF SOME ANALOGS OF PLATELET-ACTIVATING FACTOR (PAF) WITH HIGHER POTENCIES THAN NATURAL PAF

被引：12
|
作者：
KASUYA, Y [1 ]
MASUDA, Y [1 ]
SHIGENOBU, K [1 ]
机构：
[1] UNIV TOKYO,FAC PHARMACEUT SCI,DEPT CHEM PHARMACOL,BUNKYO KU,TOKYO 113,JAPAN
来源：
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 1984年 / 62卷 / 04期
关键词：
D O I：
10.1139/y84-073
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：457 / 459
页数：3
相关论文
共 50 条
  • [31] ACTION OF PLATELET-ACTIVATING FACTOR (PAF) ANTAGONISTS ON THE BRONCHOPULMONARY EFFECTS OF PAF IN THE GUINEA-PIG
    PONS, F
    TOUVAY, C
    LEJEUNE, V
    CARRE, C
    VILAIN, B
    BROQUET, C
    MENCIAHUERTA, JM
    BRAQUET, P
    JOURNAL OF LIPID MEDIATORS, 1989, 1 (06): : 329 - 340
  • [32] EFFECT OF PLATELET-ACTIVATING FACTOR (PAF) ON HUMAN-PLATELETS
    CHESNEY, CM
    PIFER, DD
    BYERS, LW
    MUIRHEAD, EE
    BLOOD, 1982, 59 (03) : 582 - 585
  • [33] ENZYMATIC ASSEMBLY OF PLATELET-ACTIVATING FACTOR (PAF-ACETHER)
    MENCIAHUERTA, JM
    NINIO, E
    LANDES, A
    GODFROID, JJ
    BENVENISTE, J
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 1015 - 1015
  • [34] INHIBITION OF PLATELET-ACTIVATING FACTOR (PAF) BINDING TO RABBIT NEUTROPHIL MEMBRANES BY PAF RECEPTOR ANTAGONISTS
    PAULSON, SK
    COX, CP
    FASEB JOURNAL, 1988, 2 (04): : A415 - A415
  • [35] Platelet-activating factor (PAF) acts as an autocrine capacitation factor.
    O'Neill, C
    Wu, CJ
    Stojanov, T
    BIOLOGY OF REPRODUCTION, 2000, 62 : 217 - 218
  • [36] DESENSITIZATION OF HUMAN-PLATELETS BY PLATELET-ACTIVATING FACTOR (PAF)
    CHESNEY, CM
    PIFER, DD
    HUCH, KM
    FEDERATION PROCEEDINGS, 1984, 43 (04) : 977 - 977
  • [37] PLATELET-ACTIVATING FACTOR (PAF-ACETHER) - PRESENT STATUS
    BENVENISTE, J
    AGENTS AND ACTIONS, 1981, 11 (6-7): : 542 - 544
  • [38] PLATELET-ACTIVATING FACTOR (PAF) BIOACTIVITY FORMATION AND LYSO-PAF ACCUMULATION IN HUMAN ARTERIES
    Tsoukatos, D. C.
    Moussis, V.
    Panopoulou, C. P.
    Christofidou, E. D.
    Koussissis, S.
    Brocheriou, I.
    Ninio, E.
    Sismanidis, S.
    Siminelakis, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 144 - 144
  • [39] RELEASE OF PLATELET-ACTIVATING FACTOR (PAF) BY MACROPHAGES DURING PHAGOCYTOSIS
    BENVENISTE, J
    MENCIAHUERTA, JM
    FEDERATION PROCEEDINGS, 1978, 37 (06) : 1554 - 1554
  • [40] Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist
    Bagnis, C
    Deray, G
    Dubois, M
    Pirotzky, E
    Jacquiaud, C
    Baghos, W
    Aupetit, B
    Braquet, P
    Jacobs, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (03) : 507 - 513
12345